Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)
NCT04454892 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2020-07-02
Summary
1. Describe the distribution of ALS in mainland China, to explore the differences in the number of ALS in different times, regions and populations in order to further explore the causes affecting the distribution of ALS;
2. To investigate the cause of ALS in mainland China in the crowd disease development process and the corresponding characteristics change ;
3. To explore the effect of prognosis of ALS;
Conditions
Interventions
- OTHER
-
AMYOTROPHIC lateral sclerosis (ALS) is a degenerative disorder of motor neurons in the cortex, brainstem and spinal cord1,2. Its cause is unknown and it is uniformly fatal, typically within five years3
Sponsors & Collaborators
-
Peking University Third Hospital
lead OTHER
Principal Investigators
-
Dongsheng Fan, MD.PHD · Peking University Third Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-01
- Primary Completion
- 2030-12-01
- Completion
- 2030-12-01
Countries
- China
Study Locations
More Related Trials
-
Correlation Between Intestinal Microflora Metabolites and Amyotrophic Lateral Sclerosis
NCT04948346 ·Status: COMPLETED
-
Determining the Safety of L-serine in ALS
NCT01835782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Application of Motor Unit Estimation Index in Amyotrophic Lateral Sclerosis and Related Diseases
NCT04956822 ·Status: UNKNOWN
-
Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis
NCT06318598 ·Status: RECRUITING
-
Efficacy and Safety of Deep Cervical Lymph Node-vein Bypass Surgery in ALS Amyotrophic Lateral Sclerosis
NCT06351735 ·Status: NOT_YET_RECRUITING
-
Neurofilament Light Chain in Amyotrophic Lateral Sclerosis
NCT06201650 ·Status: RECRUITING
-
LONgitudinal and Integrated Evaluation of Biomarkers in reLation to phenotYpe in ALS
NCT07312240 ·Status: RECRUITING ·Phase: NA
-
Methodology Study of Novel Outcome Measures to Assess Progression of ALS
NCT02611674 ·Status: COMPLETED
-
Low Dose IL-2 in the Treatment of Immune-associated ALS Syndrome
NCT04952155 ·Status: UNKNOWN ·Phase: PHASE2
-
Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients
NCT02424669 ·Status: UNKNOWN ·Phase: NA
-
Amyotrophic Lateral Sclerosis: A Multicenter Retrospective Observational Registry
NCT07143656 ·Status: ACTIVE_NOT_RECRUITING
-
A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers
NCT01495390 ·Status: COMPLETED
-
Treatment of Intravenous Infusion Plasma in Amyotrophic Lateral Sclerosis
NCT04454840 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
NCT01521728 ·Status: COMPLETED ·Phase: NA
-
Determinants of Disease Severity in Amyotrophic Lateral Sclerosis
NCT00004457 ·Status: UNKNOWN
-
Pediatric Spinal Muscular Atrophy (SMA) China Registry
NCT05042921 ·Status: ACTIVE_NOT_RECRUITING
-
Amyotrophic Lateral Sclerosis and the Innate Immune System
NCT02869048 ·Status: RECRUITING
-
Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response
NCT00753571 ·Status: UNKNOWN ·Phase: PHASE2
-
The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis
NCT01494480 ·Status: UNKNOWN ·Phase: PHASE2
-
Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis
NCT02528071 ·Status: TERMINATED
-
Compassionate Treatment : An Exploratory Clinical Trial to Assess Treatment of Amyotrophic Lateral Sclerosis
NCT02383654 ·Status: COMPLETED ·Phase: PHASE1
-
Speech Analysis in ALS Patients
NCT03868345 ·Status: COMPLETED
-
ALS Research Collaborative
NCT06885918 ·Status: RECRUITING
-
Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neurological Diseases.
NCT05852418 ·Status: RECRUITING
-
PRE-Symptomatic Studies in Amyotrophic Lateral Sclerosis
NCT01508962 ·Status: ACTIVE_NOT_RECRUITING